AAB vs BOC vs Joint Commission: How to Choose a DME Accreditation Provider
Durable medical equipment (DME) suppliers preparing to bill Medicare or expand into new payer networks first need accreditation from a Centers for Medicare & Medicaid Services (CMS)-approved deeming organization. For many suppliers, the practical question comes down to three names: AAB, BOC, and The Joint Commission. Each operates under the same federal umbrella, but their processes, costs, and reputations differ in ways that matter for a supplier's timeline, budget, and referral relationships.
Recent Trends
The accreditation landscape has shifted over the past several cycles, even as the core CMS requirements have remained stable. Suppliers evaluating these organizations today are doing so against a backdrop of tighter Medicare audit activity and a broader push toward digital documentation.
- More remote and hybrid surveys: All three accreditors have expanded virtual review options, though on-site visits remain common for initial accreditation and high-risk product categories.
- Greater emphasis on supplier compliance culture: Surveyors are increasingly looking for evidence of ongoing internal audits, not just a clean application packet.
- Consolidation in the DME market: Larger supplier groups are standardizing on a single accreditor across locations, making portability and multi-site survey models more relevant than in the past.
- State Medicaid convergence: Several state programs now accept accreditation from any CMS-approved deeming body, which reduces the historical pressure to match a specific referral network's preferences.
Background: What Each Accreditation Provider Brings
CMS approval is the common denominator. AAB, BOC, and The Joint Commission are all recognized to accredit DMEPOS suppliers, meaning Medicare Advantage plans, state agencies, and many commercial insurers will accept any of the three as proof of compliance. The meaningful differences lie in surveyor background, organizational focus, and administrative style.
- AAB (American Accreditation Board, formerly Accreditation Alliance of America): Positioned primarily as a DME-focused accreditor. Its surveyors tend to concentrate on operational supplier processes, billing workflows, and the specific product lines a supplier actually services.
- BOC (Board of Certification/Accreditation): Has deep roots in orthotic, prosthetic, and pedorthic practice. Its DME accreditation arm leverages that clinical heritage, making it a natural fit for suppliers with a strong rehab or custom-device focus.
- The Joint Commission: Best known for hospital and health-system accreditation. Its DME program is often attractive to suppliers that operate within or alongside larger healthcare organizations because it signals alignment with facility-level safety and quality standards.
Key User Concerns When Comparing Providers
Suppliers evaluating these three organizations tend to raise a consistent set of practical concerns. The right comparison framework depends less on which organization has the largest name brand and more on how each fits a supplier's specific operating reality.
- Cost structure and predictability: Initial application fees, annual fees, and per-site survey charges vary by supplier size, location, and product mix. Suppliers should request written quotes for their exact scenario rather than relying on industry averages.
- Time to survey and results: Scheduling windows can fluctuate with surveyor availability. Suppliers facing payer contract deadlines need to confirm lead times, rescheduling policies, and how quickly a certificate is issued after a clean survey.
- Documentation expectations: Each accreditor publishes its own standards manual. Some emphasize outcome metrics and patient satisfaction while others focus more on process documentation and billing compliance. The effort required to prepare can differ materially.
- Corrective action flexibility: When findings do emerge, suppliers want to know how long they have to fix issues and whether a re-survey or a desk review is triggered. Policies are not uniform.
- Referral network acceptance: While most insurers accept any CMS-approved accreditation in principle, some referral sources still operate with informal preferences based on past experience. A quick survey of current referral partners can surface those expectations before a decision is made.
- Product-specific expertise: Supplier scopes vary from complex rehab to respiratory therapy and medical supplies. An accreditor's surveyor familiarity with a given category can affect both the difficulty of the survey and the value of the feedback provided.
Likely Impact of the Choice
The accreditation decision is rarely a one-time event. Most organizations are accredited for three-year cycles, so the initial choice carries a multi-year commitment in fees, documentation systems, and staff training. The practical impact shows up in several areas.
| Area | How the Choice Matters |
|---|---|
| Revenue cycle | Delays between application, survey, and certificate issuance can hold up Medicare billing and payer contract activation. |
| Administrative burden | Documentation standards drive how much staff time is spent preparing for audits and ongoing compliance monitoring. |
| Referral relationships | Hospital-owned referral sources may view Joint Commission accreditation as a stronger signal of shared standards, while smaller clinics may have no preference at all. |
| Expansion flexibility | Suppliers that add new product lines or open new locations may need to reassess whether their current accreditor's surveyor pool and standards align with the new business model. |
None of the three organizations is inherently better across all supplier profiles. A single-location respiratory supplier, a multi-state complex rehab provider, and a hospital-owned DME department could each reach a different conclusion based on the same comparison criteria.
What to Watch Next
Because all three accreditation bodies operate under CMS oversight, future changes at the federal level will shape how meaningful their differences remain. Suppliers do not need to track every regulatory filing, but a few signals are worth monitoring.
- CMS deeming authority renewal cycles: CMS periodically reviews whether each accreditor continues to meet deeming standards. A lapse or conditional approval would have immediate implications for current and prospective clients.
- New surveyor hiring patterns: Accreditor capacity directly affects scheduling wait times. Signs of surveyor shortages may justify starting the application process earlier than planned.
- Guidance on emerging DME categories: Remote patient monitoring, non-invasive ventilators, and digital supply platforms are evolving faster than accreditation standards. Which accreditor publishes updated guidance first could influence suppliers entering those segments.
- Payer credentialing updates: Some commercial insurers and managed Medicare plans are tightening or loosening their own accreditation requirements. Even non-Medicare suppliers should verify whether their primary payers have shifted expectations.
The safest approach for any supplier is to request current materials from all three organizations, compare them against the supplier's own product lines and staffing model, and seek references from similarly sized suppliers that recently completed the process. Accreditation is a compliance milestone, but the right provider makes it a manageable part of running a DME business rather than a recurring obstacle.